Deerfield International Master Fund, L.P., 10% Owner at Vanda Pharmaceuticals Inc. (VNDA), bought 162,014 shares at $14.23 ($2.3M) on 2014-12-23, disclosed to the SEC on 2014-12-24.
Open-market purchase of $2.3M VNDA by 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $14.23 | 13,900 | $198K | 8.5% |
| 2 | $14.23 | 11,100 | $158K | 6.8% |
| 3 | $14.30 | 13,900 | $199K | 8.5% |
| 4 | $14.30 | 11,100 | $159K | 6.8% |
| 5 | $14.33 | 8,880 | $127K | 5.5% |
| 6 | $14.33 | 11,120 |
| $159K |
| 6.8% |
| 7 | $14.48 | 13,320 | $193K | 8.3% |
| 8 | $14.48 | 16,434 | $238K | 10.2% |
| 9 | $14.48 | 16,680 | $242K | 10.4% |
| 10 | $14.48 | 20,580 | $298K | 12.8% |
| 11 | $14.50 | 11,100 | $161K | 6.9% |
| 12 | $14.50 | 13,900 | $202K | 8.6% |
| Total | $14.40 avg | 162,014 | $2.3M | 100% |
| Filing → |
| VNDA | SELL | 2016-09-19 | $8.6M | — | Filing → |
| EHTH | SELL | 2016-06-08 | $488K | — | Filing → |
| ZFGN | BUY | 2016-02-17 | $177K | — | Filing → |